You are here: Home » News-IANS » Health-Medicine
Business Standard

LifeCell becomes India's top cord blood stem cell registry

IANS  |  Chennai 

LifeCell, with over 5,000 qualified units of cord blood available for sharing even with an unrelated patient, has become India's biggest cord blood stem cell registry, a statement said on Monday.

Within just four months of its launch, the stem cell bank has surpassed the collective number of cord blood units preserved with public banks in India, where the probability of finding a match has been low.

Over 70 per cent of Indian patients requiring donor stem cells are left in the lurch.

But with the community banking model at LifeCell amalgamating the open access of a public bank with the availability of vast yet under-utilised stem cell resources of a private bank, things changed, Mayur Abhaya, LifeCell CEO, said.

Abhaya said all this was at no additional cost and within the framework of the community. "This has laid the ground for the creation of an unprecedented Indian origin stem cell registry."

LifeCell plans to expand its existing customer base. Upgrading the community banking model, it will grow 10 times larger by the end of the year, the release said.

It plans to give every patient access to a well matched cord blood unit vital for a life-saving transplant.

All the units in the registry meet the current US Food and Drug Administration (FDA) standards for listing.

LifeCell will also undertake the high-cost, high resolution HLA typing of samples, based on next generation sequencing.

This brings a host of benefits, including a greater chance of finding a match.

Better matching will lead to better treatment outcomes, giving transplant physicians the confidence on the quality of the sample.

"Our hi-resolution sequencing of HLA typing would escalate the standards in the search of matching units for transplants," Abhaya added.



(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, August 07 2017. 17:20 IST